Literature DB >> 23274325

Fungal infection in patients after liver transplantation in years 2003 to 2012.

Chun-Hua Yang1, Xiao-Shun He, Juan Chen, Bin Ouyang, Xiao-Feng Zhu, Min-Ying Chen, Wen-Feng Xie, Li Chen, Dong-Hua Zheng, Yun Zhong, Xue-Xia Chen, Xiang-Dong Guan.   

Abstract

BACKGROUND: Fungal infections after liver transplantation have received considerable interests because of their association with substantial morbidity and mortality. This study investigated risk factors of fungal infection after liver transplantation. MATERIAL/
METHODS: Retrospective analysis was performed based on clinical data from 120 patients with fungal infection after liver transplantation from January 1, 2003 to May 30, 2012. χ2 test was used to analyze risk factors for fungal infections.
RESULTS: The fungal infection rate after liver transplantation is 13.5% (120/886) and the case fatality rate reaches 70.8%; most are infected by Candida albicans (67.5%), with infection located in the lung (73.3%). Acute physiology and chronic health evaluation scores of the infected group are higher than those of the control group 24 hours after the surgery (27.1±5.2 vs. 21.9±5.0). The percentage of primary liver cancer patients in the infected group was lower than in the control group (26.7% vs. 45.8%). Compared to the control group, the infected group had a higher percentage of patients with HBV, gestational diabetes mellitus, and multiple organ dysfunction syndrome. Percentages of patients with long continuous parenteral nutrition time, poorly controlled high blood sugar, long-term mechanical ventilation, and antibiotics use were higher in the infected group than in the control group.
CONCLUSIONS: Preoperative original attack, postoperative critical condition, chronically high blood sugar, long-term use of antibiotics, and mechanical ventilation are probably vital risk factors for fungal infection after liver transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 23274325     DOI: 10.12659/aot.883695

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  10 in total

1.  Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.

Authors:  E Levesque; S El Anbassi; E Sitterle; F Foulet; J C Merle; F Botterel
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

2.  Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.

Authors:  M Lackner; M Tscherner; M Schaller; K Kuchler; C Mair; B Sartori; F Istel; M C Arendrup; C Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

3.  Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.

Authors:  Faouzi Saliba; Andreas Pascher; Olivier Cointault; Pierre-François Laterre; Carlos Cervera; Jan J De Waele; Umberto Cillo; Róbert M Langer; Manuela Lugano; Bo Göran-Ericzon; Stephen Phillips; Lorraine Tweddle; Andreas Karas; Malcolm Brown; Lutz Fischer
Journal:  Clin Infect Dis       Date:  2014-12-17       Impact factor: 9.079

4.  Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach.

Authors:  Yi-Chan Chen; Ting-Shuo Huang; Yu-Chao Wang; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jun Wu; Hong-Shiue Chou; Kun-Ming Chan; Wei-Chen Lee; Ruey-Shyang Soong
Journal:  Biomed Res Int       Date:  2016-09-26       Impact factor: 3.411

5.  Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.

Authors:  Eric Levesque; Fadi Rizk; Zaid Noorah; Nawel Aït-Ammar; Catherine Cordonnier-Jourdin; Sarra El Anbassi; Christine Bonnal; Daniel Azoulay; Jean-Claude Merle; Françoise Botterel
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

6.  Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessia Carnelutti; Elda Righi; Maria Merelli; Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Assunta Sartor; Joost Wauters; Katrien Lagrou; Carlo Tascini; Francesco Menichetti; Alessio Mesini; Francesco G De Rosa; Leonel Lagunes; Jordi Rello; Arnaldo L Colombo; Antonio Vena; Patricia Munoz; Mario Tumbarello; Gabriele Sganga; Ignacio Martin-Loeches; Claudio Viscoli
Journal:  Transplant Direct       Date:  2017-04-18

7.  Long-term mortality predictors of ICU fungaemia.

Authors:  Peng Xie; Wenqiang Wang; Maolong Dong
Journal:  Epidemiol Infect       Date:  2021-10-18       Impact factor: 2.451

8.  Comprehensive analysis of peripheral blood non-coding RNAs identifies a diagnostic panel for fungal infection after transplantation.

Authors:  Anli Yang; Huadi Chen; Jianwei Lin; Ming Han; Xiaopeng Yuan; Tao Zhang; Qingwei Nian; Mengran Peng; Dian Li; Chenglin Wu; Xiaoshun He
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate.

Authors:  Debora Afonso Silva Rocha; Leandro Figueira Reis de Sa; Ana Carolina Cartagenes Pinto; Maria de Lourdes Junqueira; Emiliana Mandarano da Silva; Ronaldo Mohana Borges; Antonio Ferreira-Pereira
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-05       Impact factor: 2.743

10.  Risk-Based Estimate of Human Fungal Disease Burden, China.

Authors:  Ling-Hong Zhou; Ying-Kui Jiang; Ruo-Yu Li; Li-Ping Huang; Ching-Wan Yip; David W Denning; Li-Ping Zhu
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.